As we move forward with clinical research for our anti-aging glycopeptide, AAGP®, we continue to uncover new areas of opportunity for the molecule. See how AAGP® is helping to provide more hope for patients and investors in the areas of ophthalmology, transplants, dermatology and biomanufacturing.
byprotokinetixp
byprotokinetixp
AAGP® | Diabetes | Diabetes Symptoms | Islet Cell Transplants | Retinal Cell Transplants | Type 1 Diabetes
byprotokinetixp
AAGP® | Diabetes | Islet Cell Transplants | Retinal Cell Transplants | Type 1 Diabetes | Type 1 Diabetes Diagnosis | Type 1 Diabetes Treatment
Talk to a member of the ProtoKinetix team to learn more about our research and results.